CURI vs GTN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 12, 2026

CURI

25.7
AI Score
VS
GTN Wins

GTN

30.5
AI Score

Investment Advisor Scores

CURI

26score
Recommendation
SELL

GTN

31score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric CURI GTN Winner
Revenue 15.16M 1.61B GTN
Net Income -1.33M -6.00M CURI
Net Margin -8.8% -0.4% GTN
Operating Income -1.54M 217.00M GTN
ROE -3.6% -0.3% GTN
ROA -1.9% -0.1% GTN
Total Assets 69.16M 10.44B GTN
Cash 16.90M 176.00M GTN
Current Ratio 0.95 0.95 GTN

Relative Price Performance (Last 90 Days)

CURI 1M: +7.3% · 3M: -7.9% GTN 1M: +27.0% · 3M: +13.1%

Current Technical Phase

CURI

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 62

RSI (14): 62.0 · Price: $2.80

GTN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 61

RSI (14): 61.1 · Price: $4.84

Fundamentals Snapshot

Metric CURI GTN
Market Cap
Forward P/E 11.7 -20.2
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.1%
Gross Margin 0.6% 0.3%
Operating Margin -0.1% 0.2%
EPS -0.14 -0.58
Dividend Yield 0.11% 0.06%

Frequently Asked Questions

Based on our detailed analysis, GTN is currently the stronger investment candidate, winning 8 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.